Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline PK before and after Roux-en-Y gastric bypass
NCT01214382Phase 3Completed
- Sponsor
- North Dakota State University
- Start
- Oct 2010
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sertraline in major depressive disorder (MDD), sponsored by North Dakota State University. Primary endpoint: Area Under the Curve at 72 hours. Started Oct 2010; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01214382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214382.